Skip to main content
OpenTrials
Completed

NCT Number: NCT01036646

User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity

This multi-center study is designed to evaluate the ability of intended lay users (patients on oral anticoagulation therapy, OAT, or their caregivers) to 1) operate the INRatio Prothrombin Time (PT) Monitoring System utilizing the INRatio test strip newly designed for low sample volume and heparin insensitivity, and 2) obtain accurate results for the quantitative determination of International Normalized Ratio (INR) when self-testing using fingerstick capillary blood. Patients will be trained by their healthcare provider using the instructions for use and product labeling provided. The accuracy of the patient INR results will be assessed by comparison to the INR results obtained by the site's trained healthcare professional using the same INRatio system (from a separate fingerstick collected from the same patient at the point-of-care), and with the INR results obtained on venous plasma obtained from the same patient and analyzed at a central laboratory with the Sysmex CA-560 System INR reference method.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Loma Linda VA Hospital, Loma Linda, California, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults (18 years of age or older);
  • Ability to read and speak English;
  • Subjects on stable oral anticoagulation therapy with warfarin (at least 3 months);
  • Target INR interval between 2.0 and 4.5
  • Willing and able to provide written informed consent and comply with study procedures;

Exclusion criteria

  • Hematocrit less than 25 or greater than 55%
  • Lupus or antiphospholipid syndrome (APS)
  • Already participated in this study
  • A current INRatio PT Monitoring System User / Patient Self Tester

Treatment and study plan

Primary outcomes

  1. Operate the INRatio Prothrombin Time (PT) Monitoring System utilizing the INRatio test strip newly designed for low sample volume and heparin insensitivity.

    Time frame: 8 weeks

Sponsors and collaborators

Lead sponsor

Abbott RDx Cardiometabolic

Other

Registry information

Acronym: ECLIPSE-02

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Dec 21, 2009
Registry last updated
Feb 11, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.